In 2019, the Advisory Council on the Implementation of National Pharmacare delivered a 172-page report to the federal government with a clear conclusion: Canada was the only country in the developed world with universal health insurance that did not cover prescription drugs. The council recommended a fully universal single-payer pharmacare system. The federal government thanked the council, shelved the report, and called two elections. In 2026, seven years later, approximately 7.5 million Canadians still cannot reliably afford their prescription medications.
As The Northern Star has investigated across reporting on the affordability crisis crushing Canadian household budgets, the structural economic pressures eroding working-class financial security, and labour market policies that leave the most vulnerable most exposed, the pharmacare gap is not a minor administrative failure. It is a political choice — made repeatedly, across multiple governments, over four decades — with quantifiable human costs.
1. What Canada’s 2024 Pharmacare Act Actually Covers
The Canada Pharmacare Act, passed in 2024 as a condition of the NDP supply-and-confidence agreement, represented a real — if narrow — first step. It is critical to understand what it actually covers, because the political framing has consistently overstated its scope:
- Diabetes medications and devices: The Act’s first phase covers a defined list of diabetes drugs (insulin, metformin, GLP-1 agonists) and diabetes monitoring devices (continuous glucose monitors, test strips) for uninsured and underinsured Canadians. This addresses approximately 3.7 million Canadians with diagnosed diabetes who previously paid out-of-pocket or rationed doses.
- Contraceptives: A defined list of contraceptive medications and devices is covered under the Act’s first phase for uninsured Canadians.
- Everything else: Not covered. Cancer drugs, cardiovascular medications, mental health prescriptions, antibiotics, pain management, respiratory medications — all remain outside the Act’s current scope.
The Hoskins Advisory Council estimated a fully universal pharmacare system would require approximately $15.3 billion in annual federal spending. The 2024 Act committed to $1.5 billion over five years for its narrow first phase — roughly 2% of the estimated full program cost.
2. Who Bears the Gap: The Demographics of Prescription Poverty
The 7.5 million Canadians who cannot reliably afford prescriptions are not uniformly distributed. Structural patterns reveal where the political failure lands hardest:
Canada Prescription Drug Affordability Gap — Population Profile (2026)
| Population Group | Est. Affected (Unable to Afford Rx) | Primary Coverage Gap |
|---|---|---|
| Part-time / gig / contract workers | ~2.1 million | No employer benefit plan; ineligible for provincial welfare drug plans |
| Seniors not on provincial plans | ~1.4 million | Provincial senior drug plans vary wildly; many have high deductibles |
| Self-employed workers | ~1.1 million | Private insurance premiums for solo coverage are prohibitive |
| Unemployed / between jobs | ~890,000 | EI does not cover benefits; provincial welfare drug plans require means-testing |
| Indigenous Canadians (off-reserve) | ~620,000 | Non-Insured Health Benefits (NIHB) coverage gaps for off-reserve status members |
People Also Ask
Does Canada have universal pharmacare in 2026?
No. Canada’s 2024 Pharmacare Act covers only diabetes medications, devices, and contraceptives for uninsured Canadians. The remaining prescription drug categories — including cancer drugs, cardiovascular medications, and mental health prescriptions — are not covered federally.
How many Canadians can’t afford their prescriptions?
Approximately 7.5 million Canadians cannot reliably afford their prescription medications in 2026, according to a composite of data from the Canadian Institute for Health Information, Statistics Canada, and the Angus Reid Institute.
What does the Canada Pharmacare Act cover?
The Canada Pharmacare Act (2024) covers a defined list of diabetes medications and devices, and a defined list of contraceptives, for Canadians without private or provincial drug coverage. All other drug categories remain outside the Act’s current scope.